Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-14 15:47:32 UTC |
---|
HMDB ID | HMDB0001497 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nicotine-1'-N-oxide |
---|
Description | Nicotine-1'-N-oxide belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. In humans, nicotine-1'-N-oxide is involved in the nicotine metabolism pathway. Nicotine-1'-N-oxide has been detected, but not quantified in, several different foods, such as black chokeberries (Photinia melanocarpa), garden onions (Allium cepa), barleys (Hordeum vulgare), gooseberries (Ribes uva-crispa), and highbush blueberries (Vaccinium corymbosum). This could make nicotine-1'-N-oxide a potential biomarker for the consumption of these foods. Nicotine-1'-N-oxide is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Nicotine-1'-N-oxide. |
---|
Structure | C[N+]1([O-])CCCC1C1=CN=CC=C1 InChI=1S/C10H14N2O/c1-12(13)7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3 |
---|
Synonyms | Value | Source |
---|
1-Methyl-2-(3-pyridyl)-2,3,4,5-tetrahydropyrrol-1-olate | ChEBI | 3-(1-Methyl-1-oxidopyrrolidin-2-yl)pyridine | ChEBI | Nicotine 1-N-oxide | ChEBI | 1-Methyl-2-(3-pyridyl)-2,3,4,5-tetrahydropyrrol-1-olic acid | Generator | (1's,2's)-Nicotine-n'-oxide | HMDB | (2S)-N-Oxide 3-(1-methyl-2-pyrrolidinyl)-pyridine | HMDB | 1'-Oxide nicotine | HMDB | 1-Methyl-2-(3-pyridyl)pyrrolidine 1-oxide | HMDB | 3-(1-Methyl-1-oxido-2-pyrrolidinyl)pyridine | HMDB | N-Oxide 3-(1-methyl-2-pyrrolidinyl)pyridine | HMDB | N-Oxide-(1-methyl-2-pyrrolidinyl)pyridine | HMDB | Nicotine 1'-oxide | HMDB | Nicotine n'-oxide | HMDB | Nicotine N(1')-oxide | HMDB | Nicotine-1'-oxide | HMDB, MeSH | Nicotine 1-N-oxide, (R)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, dihydrochloride, (S)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, (1S-cis)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, (1S-trans)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, (2S)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, 14C-labeled CPD | MeSH, HMDB | Nicotine 1-N-oxide, dihydrochloride, (1S-trans)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, (1R-cis)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, (1R-trans)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, (S)-isomer | MeSH, HMDB | Nicotine 1-N-oxide, dihydrochloride, (1R-trans)-isomer | MeSH, HMDB |
| Show more...
---|
Chemical Formula | C10H14N2O |
---|
Average Molecular Weight | 178.231 |
---|
Monoisotopic Molecular Weight | 178.11061308 |
---|
IUPAC Name | 1-methyl-2-(pyridin-3-yl)pyrrolidin-1-ium-1-olate |
---|
Traditional Name | nicotine 1-N-oxide |
---|
CAS Registry Number | 63551-14-4 |
---|
SMILES | C[N+]1([O-])CCCC1C1=CN=CC=C1 |
---|
InChI Identifier | InChI=1S/C10H14N2O/c1-12(13)7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3 |
---|
InChI Key | RWFBQHICRCUQJJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrrolidinylpyridines. Pyrrolidinylpyridines are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pyrrolidinylpyridines |
---|
Direct Parent | Pyrrolidinylpyridines |
---|
Alternative Parents | |
---|
Substituents | - Pyrrolidinylpyridine
- Alkaloid or derivatives
- N-alkylpyrrolidine
- Trialkyl amine oxide
- Heteroaromatic compound
- Pyrrolidine
- Azacycle
- N-oxide
- Trisubstituted n-oxide
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organic zwitterion
- Organic nitrogen compound
- Organonitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | -79 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1000 mg/mL | Not Available | LogP | 1.17 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Nicotine-1'-N-oxide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0f96-8900000000-b2b7dd335c3a05aa57bb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nicotine-1'-N-oxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nicotine-1'-N-oxide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Nicotine-1'-N-oxide 6V, Positive-QTOF | splash10-00pi-0900000000-43724ee9d877fcb632a3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 10V, Positive-QTOF | splash10-004i-0900000000-c5515911fcd12c368c31 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 20V, Positive-QTOF | splash10-004l-5900000000-c464534b639004ad3b54 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 40V, Positive-QTOF | splash10-0uec-9300000000-2a2d1afce79d8998d3b3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 10V, Negative-QTOF | splash10-004i-0900000000-4f451a2d6c2540a25c95 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 20V, Negative-QTOF | splash10-004i-0900000000-7b621173e20fa3dd7ce0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 40V, Negative-QTOF | splash10-0fb9-7900000000-1d685bcb46ea923561a3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 10V, Negative-QTOF | splash10-004i-0900000000-403f45bf7fa583376662 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 20V, Negative-QTOF | splash10-004i-0900000000-403f45bf7fa583376662 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 40V, Negative-QTOF | splash10-004i-9000000000-c2850ce6846335b0374d | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 10V, Positive-QTOF | splash10-004i-0900000000-d33bcccb60db843c9005 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 20V, Positive-QTOF | splash10-03di-1900000000-c1bca04af770521cb894 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nicotine-1'-N-oxide 40V, Positive-QTOF | splash10-0059-9500000000-d593bd18e59fdd3ed294 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | - Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Adrenal Medulla
- Bladder
- Brain
- Epidermis
- Fibroblasts
- Hair
- Kidney
- Liver
- Lung
- Neuron
- Pancreas
- Placenta
- Platelet
- Skeletal Muscle
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022656 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 396 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 409 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 30734 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Urakawa N, Nagata T, Kudo K, Kimura K, Imamura T: Simultaneous determination of nicotine and cotinine in various human tissues using capillary gas chromatography/mass spectrometry. Int J Legal Med. 1994;106(5):232-6. [PubMed:8068568 ]
- Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N: Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther. 2006 Jun;79(6):600-8. Epub 2006 May 11. [PubMed:16765148 ]
- Court JA, Johnson M, Religa D, Keverne J, Kalaria R, Jaros E, McKeith IG, Perry R, Naslund J, Perry EK: Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking. Neuropathol Appl Neurobiol. 2005 Oct;31(5):522-35. [PubMed:16150123 ]
- LeSage MG, Keyler DE, Pentel PR: Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies. AAPS J. 2006 Feb 24;8(1):E65-75. [PubMed:16584135 ]
- Fang Y, Svoboda KK: Nicotine inhibits myofibroblast differentiation in human gingival fibroblasts. J Cell Biochem. 2005 Aug 15;95(6):1108-19. [PubMed:15962330 ]
- Eliasson B, Smith U, Lonnroth P: No acute effects of smoking and nicotine nasal spray on lipolysis measured by subcutaneous microdialysis. Eur J Clin Invest. 1997 Jun;27(6):503-9. [PubMed:9229231 ]
- Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, Sayyah J, Dennis PA: Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis. 2005 Jul;26(7):1182-95. Epub 2005 Mar 24. [PubMed:15790591 ]
- Ramachandran J, Rubenstein D, Bluestein D, Jesty J: Activation of platelets exposed to shear stress in the presence of smoke extracts of low-nicotine and zero-nicotine cigarettes: the protective effect of nicotine. Nicotine Tob Res. 2004 Oct;6(5):835-41. [PubMed:15700919 ]
- Miller VM, Lewis DA, Rud KS, Offord KP, Croghan IT, Hurt RD: Plasma nitric oxide before and after smoking cessation with nicotine nasal spray. J Clin Pharmacol. 1998 Jan;38(1):22-7. [PubMed:9597555 ]
- Hureiki J, Laqueille X: [The Tuaregs addiction to tea, to smokeless tobacco and to milk: ethnological and clinical approach]. Encephale. 2003 Jan-Feb;29(1):42-8. [PubMed:12640326 ]
- Bonci A, Bernardi G, Grillner P, Mercuri NB: The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? Trends Pharmacol Sci. 2003 Apr;24(4):172-7. [PubMed:12707003 ]
- Nadler JL, Velasco JS, Horton R: Cigarette smoking inhibits prostacyclin formation. Lancet. 1983 Jun 4;1(8336):1248-50. [PubMed:6134041 ]
- Terry AV Jr, Hernandez CM, Hohnadel EJ, Bouchard KP, Buccafusco JJ: Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition. CNS Drug Rev. 2005 Autumn;11(3):229-52. [PubMed:16389292 ]
- Reddy A, Sood A, Rust PF, Busby JE, Varn E, Mathur RS, Mathur S: The effect of nicotine on in vitro sperm motion characteristics. J Assist Reprod Genet. 1995 Mar;12(3):217-23. [PubMed:8520189 ]
- Joshi M, Tyndale RF: Regional and cellular distribution of CYP2E1 in monkey brain and its induction by chronic nicotine. Neuropharmacology. 2006 Apr;50(5):568-75. Epub 2005 Dec 20. [PubMed:16368115 ]
- Marchei E, Durgbanshi A, Rossi S, Garcia-Algar O, Zuccaro P, Pichini S: Determination of arecoline (areca nut alkaloid) and nicotine in hair by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. Rapid Commun Mass Spectrom. 2005;19(22):3416-8. [PubMed:16259042 ]
- Maurer P, Jennings GT, Willers J, Rohner F, Lindman Y, Roubicek K, Renner WA, Muller P, Bachmann MF: A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Eur J Immunol. 2005 Jul;35(7):2031-40. [PubMed:15971275 ]
- Lambers DS, Clark KE: The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996 Apr;20(2):115-26. [PubMed:8857697 ]
- Hansson L, Choudry NB, Karlsson JA, Fuller RW: Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. J Appl Physiol (1985). 1994 Jun;76(6):2420-7. [PubMed:7928866 ]
- Warner DO, Joyner MJ, Charkoudian N: Nicotine increases initial blood flow responses to local heating of human non-glabrous skin. J Physiol. 2004 Sep 15;559(Pt 3):975-84. Epub 2004 Jul 22. [PubMed:15272048 ]
| Show more...
---|